HHLR ADVISORS, LTD.
Institutional investor · Portfolio as of Q1 2021
Top Holdings91 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
BEIGENE LTD-ADR | 5.5M | $1.9B | 18.8% | $134.02 | +148.46% | 10 qtrssince 2018-Q4 | Unchanged 0 |
PDD HOLDINGS INC | 10.2M | $1.4B | 13.5% | $34.04 | +297.83% | 10 qtrssince 2018-Q4 | Decreased 0 |
IQIYI INC | 38.6M | $642.3M | 6.3% | $18.39 | -6.42% | 10 qtrssince 2018-Q4 | Unchanged 0 |
ZOOM COMMUNICATIONS INC | 2M | $634.9M | 6.3% | $84.35 | +271.28% | 6 qtrssince 2019-Q4 | Decreased 0 |
ENSTAR GROUP LIMITED | 1.7M | $431.2M | 4.3% | — | — | 9 qtrssince 2019-Q1 | Unchanged 0 |
UBER TECHNOLOGIES INC | 6.8M | $370.2M | 3.7% | $29.72 | +79.88% | 7 qtrssince 2019-Q3 | Decreased 0 |
JD.COM INC-ADR | 4.2M | $351M | 3.5% | $44.76 | +68.25% | 10 qtrssince 2018-Q4 | Decreased 0 |
CHINA BIOLOGIC PRODS HLDGS I | 3M | $350.7M | 3.5% | — | — | 10 qtrssince 2018-Q4 | Unchanged 0 |
BRIDGEBIO PHARMA INC | 5.4M | $330.3M | 3.3% | $28.25 | +109.24% | 8 qtrssince 2019-Q2 | Increased 65 |
NOVABRIDGE BIOSCIENCES | 6.6M | $320.7M | 3.2% | $45.18 | +4.40% | 3 qtrssince 2020-Q3 | Increased 92 |
KE HOLDINGS INC-ADR | 5M | $285.6M | 2.8% | $62.02 | -13.14% | 3 qtrssince 2020-Q3 | Increased 53 |
GDS Holdings Ltd. Sponsored ADR Class A | 3.1M | $254.9M | 2.5% | $80.16 | -0.47% | 4 qtrssince 2020-Q2 | Unchanged 0 |
SALESFORCE.COM INC | 1.1M | $240.8M | 2.4% | $184.99 | +12.16% | 5 qtrssince 2020-Q1 | Increased 56 |
BILIBILI INC-SPONSORED ADR | 2M | $213.9M | 2.1% | $15.50 | +577.88% | 10 qtrssince 2018-Q4 | Decreased 0 |
APELLIS PHARMACEUTICALS INC | 4.6M | $195.6M | 1.9% | $19.43 | +116.47% | 10 qtrssince 2018-Q4 | Decreased 0 |
BEAM THERAPEUTICS INC | 2.1M | $165.9M | 1.6% | $18.00 | +320.89% | 5 qtrssince 2020-Q1 | Decreased 0 |
DOORDASH INC - A | 1.1M | $143.8M | 1.4% | $138.12 | -5.44% | 2 qtrssince 2020-Q4 | Increased 59 |
Kyntra Bio, Inc. | 4M | $137.3M | 1.4% | — | — | — | — |
MONDELEZ INTERNATIONAL INC-A | 1.9M | $109M | 1.1% | $33.70 | +54.60% | 10 qtrssince 2018-Q4 | Decreased 0 |
ARGENX SE - ADR | 375,540 | $103.4M | 1.0% | $216.75 | +25.61% | 6 qtrssince 2019-Q4 | Decreased 0 |
HHLR ADVISORS, LTD. manages $10.1B across 91 positions as of Q1 2021. Top holdings: ONC (18.8%), PDD (13.5%), IQ (6.3%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.
Active quarter - 13 new positions, 17 exits, 9 increased. Top move: NBP (INCREASED, conviction 92). Portfolio: $10.1B across 91 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer